We are live on ! Find out more
EW

Evoke Wealth Portfolio holdings

AUM $5.57B
1-Year Est. Return 23.85%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+23.85%
3 Year Est. Return
+55.14%
5 Year Est. Return
+52.16%
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$249M
Cap. Flow
+$122M
Cap. Flow %
8.22%
Top 10 Hldgs %
69.21%
Holding
1,106
New
57
Increased
223
Reduced
136
Closed
52

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$11.3M
2
VOD icon
Vodafone
VOD
+$10.1M
3
GLD icon
SPDR Gold Trust
GLD
+$4.28M
4
HLF icon
Herbalife
HLF
+$3.88M
5
CVX icon
Chevron
CVX
+$3.51M

Sector Composition

Rank Sector Weight
1 Financials 4.08%
2 Technology 3.32%
3 Communication Services 2.81%
4 Industrials 1.7%
5 Healthcare 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXC icon
526
Exelon
EXC
$47.2B
$15K ﹤0.01%
481
+107
+29% +$3.16K
MRSH
527
Marsh
MRSH
$90.5B
$15K ﹤0.01%
124
+1
+0.8% +$114
MRVL icon
528
Marvell Technology
MRVL
$168B
$15K ﹤0.01%
308
SHW icon
529
Sherwin-Williams
SHW
$82.7B
$15K ﹤0.01%
60
TLT icon
530
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$15K ﹤0.01%
97
TWLO icon
531
Twilio
TWLO
$30B
$15K ﹤0.01%
44
ATRC icon
532
AtriCure
ATRC
$1.92B
$14K ﹤0.01%
250
BCE icon
533
BCE
BCE
$20.2B
$14K ﹤0.01%
326
CP icon
534
Canadian Pacific Kansas City
CP
$78.1B
$14K ﹤0.01%
200
PHO icon
535
Invesco Water Resources ETF
PHO
$2.01B
$14K ﹤0.01%
300
PNC icon
536
PNC Financial Services
PNC
$99.7B
$14K ﹤0.01%
95
+47
+98% +$6K
RCL icon
537
Royal Caribbean
RCL
$85.1B
$14K ﹤0.01%
183
+26
+17% +$1.81K
ALXN
538
DELISTED
Alexion Pharmaceuticals
ALXN
$14K ﹤0.01%
92
+4
+5% +$514
BMRN icon
539
BioMarin Pharmaceuticals
BMRN
$11.6B
$13K ﹤0.01%
150
COF icon
540
Capital One
COF
$128B
$13K ﹤0.01%
133
+107
+412% +$9.1K
EW icon
541
Edwards Lifesciences
EW
$49.6B
$13K ﹤0.01%
138
HIG icon
542
Hartford Financial Services
HIG
$38.9B
$13K ﹤0.01%
270
+25
+10% +$1.08K
INCY icon
543
Incyte
INCY
$24.2B
$13K ﹤0.01%
155
NATH icon
544
Nathan's Famous
NATH
$402M
$13K ﹤0.01%
231
NTRS icon
545
Northern Trust
NTRS
$33.3B
$13K ﹤0.01%
138
-2
-1% -$176
OKTA icon
546
Okta
OKTA
$24.7B
$13K ﹤0.01%
51
ROST icon
547
Ross Stores
ROST
$80.5B
$13K ﹤0.01%
103
WELL icon
548
Welltower
WELL
$169B
$13K ﹤0.01%
208
-23
-10% -$1.4K
NATI
549
DELISTED
National Instruments Corp
NATI
$13K ﹤0.01%
+307
New +$11.5K
BDJ icon
550
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.71B
$12K ﹤0.01%
1,411

Similar funds

Evoke Wealth's Q4 2020 Portfolio in Review

As of Q4 2020, Evoke Wealth held 1,106 positions worth $1.48B, up 20% from $1.23B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Evoke Wealth deployed $122M of net new capital in Q4 2020, opening 57 new positions and adding to 223 existing holdings. Its largest new stake was Inari Medical, Inc. Common Stock: 72,256 shares worth $6.31M.

By sector, the portfolio is most concentrated in Financials at 4.1% of assets, down from 5.1% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $11.3M trimmed.

  • Evoke Wealth's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 72,256 shares worth $6.31M.
  • Evoke Wealth added most to RPAR Risk Parity ETF in Q4 2020, an estimated $78.3M increase.
  • Evoke Wealth's biggest Q4 2020 reduction was JPMorgan Chase, cutting an estimated $11.3M.
  • Evoke Wealth fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2020, selling an estimated $1.4M.
  • Evoke Wealth's ten largest holdings make up 69% of its $1.48B portfolio in Q4 2020.
  • Evoke Wealth opened 57 new positions and closed 52 in Q4 2020.
  • Evoke Wealth's portfolio value rose 20% quarter-over-quarter to $1.48B.

Based on Evoke Wealth's 13F filing for Q4 2020, filed 12 Feb 2021.